Pravastatin Sodium NDC 0480-7270

NDC codes

FDA NDC Directory

Product NDC (as listed)0480-7270Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00480-7270Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0480-7270-10	00480727010	1000 TABLET in 1 BOTTLE (0480-7270-10)Marketed from Mar 20, 2023
0480-7270-98	00480727098	90 TABLET in 1 BOTTLE (0480-7270-98)Marketed from Feb 9, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pravastatin Sodium
Generic name (nonproprietary): pravastatin sodium
Active ingredients: Pravastatin sodium — 80 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Teva Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077793
Marketing start: Feb 9, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 0480-7270_95e8c960-5096-43a9-8807-89cdf404a214SPL ID 95e8c960-5096-43a9-8807-89cdf404a214SPL set ID f66cb1c1-5ff1-4b0b-89d0-8ecaee26b0b8RxCUI 904481UNII 3M8608UQ61
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400480727010 followed by a unit qualifier and the quantity

Package 00480-7270-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2022.

Indications (excerpt from the label)

Pravastatin sodium tablets are indicated: To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD). To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD. As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia. As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077793

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077793
Product	Strength	Form · route	Labeler	Product NDC
Pravastatin sodium	Pravastatin sodium 80 mg/1	TabletOral	Aurobindo Pharma Limited	84386-034